title: Metronomic scheduling of anticancer agents for a refractory orbital pseudotumor in a child.
authors.affiliation: *Department of Pediatric Hemato-Oncology, University Hospital Marrakech, Morocco Departments of †Pediatric Hemato-Oncology ‡Radiotherapy, Children Hospital of La Timone, AP-HM §Metronomics Global Health Initiative Marseille, France.
authors.forename: Jamila
authors.initials: J
authors.lastname: Elhoudzi
authors.forename: Angélique
authors.initials: A
authors.lastname: Rome
authors.forename: Laetitia
authors.initials: L
authors.lastname: Padovani
authors.forename: Jean Claude
authors.initials: JC
authors.lastname: Gentet
authors.forename: Nicolas
authors.initials: N
authors.lastname: André
mesh_terms: D059250:Administration, Metronomic; D000893:Anti-Inflammatory Agents / Q000627:therapeutic use; D000970:Antineoplastic Agents / Q000008:administration & dosage*; D000068579:Celecoxib; D002648:Child; D003520:Cyclophosphamide / Q000008:administration & dosage*; D006801:Humans; D008297:Male; D016727:Orbital Pseudotumor / Q000188:drug therapy*; D011241:Prednisone / Q000627:therapeutic use; D011720:Pyrazoles / Q000008:administration & dosage*; D013449:Sulfonamides / Q000008:administration & dosage*
chemical_list: D000893:Anti-Inflammatory Agents; D000970:Antineoplastic Agents; D011720:Pyrazoles; D013449:Sulfonamides; D003520:Cyclophosphamide; D000068579:Celecoxib; D011241:Prednisone